Medical tourism in 2017 is estimated to cost Nigeria approximately 500Billion Naira (1.3 Billion USD) per annum.
Healthcare spending in Nigeria has reached a value of $18.35 billion, over 6.5 Trillion Naira (3.8% GDP) , extremely low by global standards. Putting Nigeria in position 187 of 190 in WHO rating
Centralized information silos a harbinger of fraud, expensive and difficult to coordinate, bulky and highly prone to loss, data theft and manipulation characterize the healthcare space
3rd party (consumer) disintermediation, hospitals, pharmacies, laboratories and insurers use same old centralized logic in decision making; completely excluding the consumer from the process NiMEDix will bridge tha gap by putting you in complete control of your health data and an opportunity to monetize your data
NIMEDIX has identified the problems of a centralized system and proffer solutions using Blockchain & Artificial Intelligence (AI).
Nimedix is combination both Blockchain + AI
Patients own their own medical records
Encrypted health data can be shared with individuals/systems chosen by patient.
Health data from patients can be shared on different application and platforms
Data is encrypted & stored on the block, which is added to the block chain
The Nimedix RoadMap
The NiMEDix Team combines a passion for healthCare and Advanced technology.
Founder /CEO NiMEDix ecosystem
Training in Benue state university teaching hospital Makurdi as a Medical doctor, Passionate student of medicine and surgery. BoT member Tower of hope foundation International (10 years+), Member world Christian medical missions (10 years+), Cryptocurrency enthusiast, ICO investor, project manager JABEN engineering Nig ltd. Understand and believes in collaboration, loves basketball and video games
Co-Founder NiMEDix Ecosystem/Lead Developer
Computer Scientist, Software Engineer, FullStack Developer, Blockchain developer with a driven passion for Deep learning and Computer Vision. Versatile in Software Development skills and a good team player. CEO A-Dev Developers Nig ltd
Graphics Designer with advance knowledge on multimedia marketting and motion graphics animation. a cryptocurrency enthusiast with good amount of years on ICO and market startups. Has good communication background with proven results especially in cryptocurrency tokens startups in Africa.
A serial adviser to ICO projects with great potentials, providing turnkey solutions, connecting them with all necessary support such as ICO consultants, marketing, Branding and community managers, crypto funds and investors, crypto exchanges, etc.
NiMEDix is a Nigerian-based organization poised to providing an innovative next-generation healthcare solution designed to meet specific patients needs and services using the AI and blockchain technology to connect doctors, hospitals, pharmacies and scientific research facilities to improve patient care.
The core of NiMEDix is grounded in the proven and tested advantages of applying AI and blockchain technology to meet vast array Africa’s health care challenges...
The appeal of AI is its ability to collect, analyze and make sense of vast amounts of unstructured and variable data (especially text, statistical numbers, and visual images) quickly and often more accurately than a human being. With the increase in digitization and computing power, there has been an ever-growing wealth of digital data produced by individuals and systems, and advances in machine learning and analytical algorithms mean AI systems will become ever more powerful and effective.
Blockchain technology will provide services for individual professionals and organizations to share patient data securely, and allow medical research institutions to collect, monitor and analyze medical data securely, reliably and safely. It will allow sensitive data in clinical trial applications to be shared consistent with rigorous privacy and ethical requirements
NiMEDix blockchain and smart contract technology can be applied to the medical AI to help conduct clinical research and routine care. It will provide a platform for clinical decision making (clinical investigation, diagnosis, etc.), management of care (treatment, workflow, monitoring, etc.), and particularly distributed services and knowledge sharing
Anyone can participate in NIM’s tokensale. Before taking part please make sure you are eligible to participate in the Nimedix token sale depending on your jurisdiction. In general, residents of the United States and Singapore can’t participate in token sales. Even if you are not a resident of United States and Singapore, please be sure to check if there are any regulatory restrictions in your country or state..
Any question? Reach out to us and we’ll get back to you shortly.
Potential purchasers of our NIM tokens (as referred to in the Whitepaper) must carefully consider and evaluate all risks and uncertainties associated with NiMEDix, NIMED (NIM) and its subsidiary business, the companies’ operations, the ICO, the NIM tokens and all information presented in this whitepaper and the NiMEDix business plan, the technical documents and all information provided on all NiMEDix associated websites and social media presences.
In case any of these uncertainties, risks or problems develops into actual events, the companies, the business operations, the Financial state of the companies, effect and results of NiMEDix operations and material provided with NiMEDix and NiMEDix could be materially and adversely afected. In case of one of these events you might lose part or all of the value of the acquired NIM tokens.
Please always advise your own tax advisor, your legal or any other professional advisor or your local authorities when you plan to participate in NiMEDix NIMED and the NIM tokens. Please always be aware that you might bear the Financial risks of any participation in the NiMEDix / NiMEDix ICO for an indefinite period.
Please Note: You are NOT eligible to buy NIM tokens if you are a citizen, resident, or green card holder of ANY NATION prohibited from participating in token sales events, should you choose to proceed you do so at your own risk. The information provided in our whitepaper has not been approved or examined by any regulatory authority of any kind. Please contact your local authorities, your lawyer or a professional advisor for further information.